Actavis Intl. Ltd. - The Rep Office in HCMC | EuroCham
Change your cover photo
Upload
Actavis Intl. Ltd. - The Rep Office in HCMC7915
Change your cover photo
This user account status is Approved

This user has not added any information to their profile yet.

Company Profile

Teva is the world’s largest generic medicines producer, leveraging its portfolio of more than 1,800 molecules to produce a wide range of generic products in nearly every therapeutic area. In specialty medicines, Teva has a world-leading position in innovative treatments for disorders of the central nervous system, including pain, as well as a strong portfolio of respiratory products. Teva integrates its generics and specialty capabilities in its global research and development division to create new ways of addressing unmet patient needs by combining drug development capabilities with devices, services and technologies. Teva's net revenues in 2016 were $21.9 billion with 58,000 employees and 87 manufacturing sites (many of which are in Europe).

In 2016 Teva Acquired Actavis. As part of this acquisition ACTAVIS INTERNATIONAL LTD - THE REPRESENTATIVE OFFICE IN HCMC became part of Teva. According to IMS data our revenues as per IMS data reached $25.2 million in 2016 becoming a Top 25 pharmaceutical company in the country. Our vision is to increase access to high quality medicines and services by implementing differentiated business models and building Teva’s brand equity with health care professionals and consumers in Vietnam.

PHARMACEUTICALS, BIOTECHNOLOGY, LIFE SCIENCES
11-25

Company Information

Actavis Intl. Ltd. - The Rep Office in HCMC

Company Profile

Company Description

Teva is the world’s largest generic medicines producer, leveraging its portfolio of more than 1,800 molecules to produce a wide range of generic products in nearly every therapeutic area. In specialty medicines, Teva has a world-leading position in innovative treatments for disorders of the central nervous system, including pain, as well as a strong portfolio of respiratory products. Teva integrates its generics and specialty capabilities in its global research and development division to create new ways of addressing unmet patient needs by combining drug development capabilities with devices, services and technologies. Teva’s net revenues in 2016 were $21.9 billion with 58,000 employees and 87 manufacturing sites (many of which are in Europe).

In 2016 Teva Acquired Actavis. As part of this acquisition ACTAVIS INTERNATIONAL LTD – THE REPRESENTATIVE OFFICE IN HCMC became part of Teva. According to IMS data our revenues as per IMS data reached $25.2 million in 2016 becoming a Top 25 pharmaceutical company in the country. Our vision is to increase access to high quality medicines and services by implementing differentiated business models and building Teva’s brand equity with health care professionals and consumers in Vietnam.

Business Category

PHARMACEUTICALS, BIOTECHNOLOGY, LIFE SCIENCES

Number of Employees in Vietnam

11-25
Company Information

Company Name

Actavis Intl. Ltd. - The Rep Office in HCMC

Address

Room 9, Floor 9, Metropolitan Building, No. 235 Dong Khoi street, District 1, Ho Chi Minh City

Telephone

+84 838228801
Representative Profiles

Log in as a member to access the details. Not a member? Contact our Membership team at (84-28) 3827 2715 ext 105 or membership@eurochamvn.org

Change your cover photo
Upload
Actavis Intl. Ltd. - The Rep Office in HCMC7915
Change your cover photo
This user account status is Approved

This user has not added any information to their profile yet.

Company Profile

Teva is the world’s largest generic medicines producer, leveraging its portfolio of more than 1,800 molecules to produce a wide range of generic products in nearly every therapeutic area. In specialty medicines, Teva has a world-leading position in innovative treatments for disorders of the central nervous system, including pain, as well as a strong portfolio of respiratory products. Teva integrates its generics and specialty capabilities in its global research and development division to create new ways of addressing unmet patient needs by combining drug development capabilities with devices, services and technologies. Teva's net revenues in 2016 were $21.9 billion with 58,000 employees and 87 manufacturing sites (many of which are in Europe).

In 2016 Teva Acquired Actavis. As part of this acquisition ACTAVIS INTERNATIONAL LTD - THE REPRESENTATIVE OFFICE IN HCMC became part of Teva. According to IMS data our revenues as per IMS data reached $25.2 million in 2016 becoming a Top 25 pharmaceutical company in the country. Our vision is to increase access to high quality medicines and services by implementing differentiated business models and building Teva’s brand equity with health care professionals and consumers in Vietnam.

PHARMACEUTICALS, BIOTECHNOLOGY, LIFE SCIENCES
11-25

Company Information

Marieke Van Der PIJL

VICE CHAIR

Corem ipsum dolor sit amet, consectetur adipiscing elit. Nunc vulputate libero et velit interdum, ac aliquet odio mattis.